nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—migraine—Prednisone—hematologic cancer	0.11	0.508	CpDpCtD
Diclofenac—osteoarthritis—Prednisone—hematologic cancer	0.106	0.492	CpDpCtD
Diclofenac—ALOX5—hematologic cancer	0.0961	0.435	CbGaD
Diclofenac—UGT1A1—hematologic cancer	0.0844	0.382	CbGaD
Diclofenac—ALB—hematologic cancer	0.0207	0.0936	CbGaD
Diclofenac—ABCB1—hematologic cancer	0.0197	0.0894	CbGaD
Diclofenac—ABCC4—Tioguanine—hematologic cancer	0.0181	0.054	CbGbCtD
Diclofenac—ABCC1—Idarubicin—hematologic cancer	0.011	0.0329	CbGbCtD
Diclofenac—PTGS2—Lenalidomide—hematologic cancer	0.00971	0.0291	CbGbCtD
Diclofenac—CYP2C18—Ifosfamide—hematologic cancer	0.00928	0.0278	CbGbCtD
Diclofenac—ABCC1—Daunorubicin—hematologic cancer	0.00778	0.0233	CbGbCtD
Diclofenac—ABCC4—Mercaptopurine—hematologic cancer	0.0075	0.0224	CbGbCtD
Diclofenac—UGT1A1—Nilotinib—hematologic cancer	0.00659	0.0197	CbGbCtD
Diclofenac—UGT2B7—Epirubicin—hematologic cancer	0.00539	0.0161	CbGbCtD
Diclofenac—CYP1A2—Anagrelide—hematologic cancer	0.00528	0.0158	CbGbCtD
Diclofenac—CYP1A1—Methoxsalen—hematologic cancer	0.00528	0.0158	CbGbCtD
Diclofenac—PTGS2—Thalidomide—hematologic cancer	0.00518	0.0155	CbGbCtD
Diclofenac—CYP2B6—Thiotepa—hematologic cancer	0.00518	0.0155	CbGbCtD
Diclofenac—SLCO1C1—Methotrexate—hematologic cancer	0.0051	0.0153	CbGbCtD
Diclofenac—PTGS1—Bortezomib—hematologic cancer	0.00503	0.015	CbGbCtD
Diclofenac—CYP1A1—Bortezomib—hematologic cancer	0.00503	0.015	CbGbCtD
Diclofenac—CYP1A1—Daunorubicin—hematologic cancer	0.00481	0.0144	CbGbCtD
Diclofenac—ABCC1—Mitoxantrone—hematologic cancer	0.00473	0.0142	CbGbCtD
Diclofenac—SLC22A8—Mercaptopurine—hematologic cancer	0.00469	0.014	CbGbCtD
Diclofenac—UGT1A1—Irinotecan—hematologic cancer	0.00453	0.0136	CbGbCtD
Diclofenac—CYP1A1—Thalidomide—hematologic cancer	0.00438	0.0131	CbGbCtD
Diclofenac—PTGS1—Thalidomide—hematologic cancer	0.00438	0.0131	CbGbCtD
Diclofenac—PTGS1—Ifosfamide—hematologic cancer	0.00385	0.0115	CbGbCtD
Diclofenac—ABCC1—Epirubicin—hematologic cancer	0.00383	0.0115	CbGbCtD
Diclofenac—CYP1A1—Dacarbazine—hematologic cancer	0.00377	0.0113	CbGbCtD
Diclofenac—ABCC1—Irinotecan—hematologic cancer	0.00372	0.0111	CbGbCtD
Diclofenac—PTGS1—Imatinib—hematologic cancer	0.00368	0.011	CbGbCtD
Diclofenac—UGT1A1—Etoposide—hematologic cancer	0.00363	0.0109	CbGbCtD
Diclofenac—PTGS2—Triamcinolone—hematologic cancer	0.00359	0.0108	CbGbCtD
Diclofenac—CYP2E1—Thalidomide—hematologic cancer	0.00338	0.0101	CbGbCtD
Diclofenac—ABCC1—Vinblastine—hematologic cancer	0.00331	0.00991	CbGbCtD
Diclofenac—CYP2C9—Bexarotene—hematologic cancer	0.0033	0.00988	CbGbCtD
Diclofenac—ABCC1—Vincristine—hematologic cancer	0.00325	0.00974	CbGbCtD
Diclofenac—ABCB1—Lenalidomide—hematologic cancer	0.0032	0.00958	CbGbCtD
Diclofenac—PTGS2—Betamethasone—hematologic cancer	0.00308	0.00923	CbGbCtD
Diclofenac—ABCC1—Etoposide—hematologic cancer	0.00298	0.00892	CbGbCtD
Diclofenac—CYP1A1—Dasatinib—hematologic cancer	0.00296	0.00885	CbGbCtD
Diclofenac—CYP2B6—Ifosfamide—hematologic cancer	0.00294	0.00879	CbGbCtD
Diclofenac—CYP2E1—Dacarbazine—hematologic cancer	0.00291	0.0087	CbGbCtD
Diclofenac—CYP2C8—Bortezomib—hematologic cancer	0.0029	0.00868	CbGbCtD
Diclofenac—CYP1A2—Carmustine—hematologic cancer	0.00278	0.00831	CbGbCtD
Diclofenac—ALB—Imatinib—hematologic cancer	0.00275	0.00823	CbGbCtD
Diclofenac—CYP2C9—Idarubicin—hematologic cancer	0.00273	0.00818	CbGbCtD
Diclofenac—SLC22A11—Methotrexate—hematologic cancer	0.00263	0.00788	CbGbCtD
Diclofenac—CYP2B6—Nilotinib—hematologic cancer	0.00255	0.00763	CbGbCtD
Diclofenac—ABCC4—Methotrexate—hematologic cancer	0.00245	0.00734	CbGbCtD
Diclofenac—CYP2C19—Bortezomib—hematologic cancer	0.00243	0.00728	CbGbCtD
Diclofenac—CYP1A2—Methoxsalen—hematologic cancer	0.00236	0.00706	CbGbCtD
Diclofenac—CYP2E1—Mitoxantrone—hematologic cancer	0.00226	0.00675	CbGbCtD
Diclofenac—CYP1A2—Bortezomib—hematologic cancer	0.00225	0.00672	CbGbCtD
Diclofenac—CYP2C8—Ifosfamide—hematologic cancer	0.00222	0.00666	CbGbCtD
Diclofenac—PTGS2—Cisplatin—hematologic cancer	0.00222	0.00664	CbGbCtD
Diclofenac—PTGS2—Etoposide—hematologic cancer	0.00218	0.00653	CbGbCtD
Diclofenac—CYP1A2—Daunorubicin—hematologic cancer	0.00215	0.00643	CbGbCtD
Diclofenac—CYP2C19—Thalidomide—hematologic cancer	0.00212	0.00634	CbGbCtD
Diclofenac—CYP1A2—Alitretinoin—hematologic cancer	0.0021	0.0063	CbGbCtD
Diclofenac—ABCC1—Doxorubicin—hematologic cancer	0.00203	0.00609	CbGbCtD
Diclofenac—CYP2C9—Bortezomib—hematologic cancer	0.00202	0.00605	CbGbCtD
Diclofenac—CYP2C19—Teniposide—hematologic cancer	0.00202	0.00605	CbGbCtD
Diclofenac—ABCC1—Methotrexate—hematologic cancer	0.00197	0.0059	CbGbCtD
Diclofenac—CYP1A2—Thalidomide—hematologic cancer	0.00196	0.00585	CbGbCtD
Diclofenac—CYP2C8—Nilotinib—hematologic cancer	0.00193	0.00578	CbGbCtD
Diclofenac—CYP3A4—Bexarotene—hematologic cancer	0.00192	0.00574	CbGbCtD
Diclofenac—ABCB1—Daunorubicin—hematologic cancer	0.00188	0.00562	CbGbCtD
Diclofenac—CYP2C19—Ifosfamide—hematologic cancer	0.00187	0.00558	CbGbCtD
Diclofenac—PTGS1—Etoposide—hematologic cancer	0.00184	0.00551	CbGbCtD
Diclofenac—ABCB1—Alitretinoin—hematologic cancer	0.00184	0.0055	CbGbCtD
Diclofenac—ALB—Prednisone—hematologic cancer	0.00181	0.00542	CbGbCtD
Diclofenac—PTGS2—Dexamethasone—hematologic cancer	0.00179	0.00537	CbGbCtD
Diclofenac—CYP3A4—Lomustine—hematologic cancer	0.00178	0.00534	CbGbCtD
Diclofenac—CYP3A4—Busulfan—hematologic cancer	0.00178	0.00534	CbGbCtD
Diclofenac—CYP2C19—Imatinib—hematologic cancer	0.00178	0.00533	CbGbCtD
Diclofenac—CYP2C9—Thalidomide—hematologic cancer	0.00176	0.00527	CbGbCtD
Diclofenac—CYP2B6—Irinotecan—hematologic cancer	0.00175	0.00524	CbGbCtD
Diclofenac—ALB—Irinotecan—hematologic cancer	0.00172	0.00514	CbGbCtD
Diclofenac—PTGS2—ovarian follicle—hematologic cancer	0.00168	0.0563	CbGeAlD
Diclofenac—CYP1A2—Dacarbazine—hematologic cancer	0.00168	0.00503	CbGbCtD
Diclofenac—CYP2C9—Teniposide—hematologic cancer	0.00168	0.00503	CbGbCtD
Diclofenac—CYP1A2—Imatinib—hematologic cancer	0.00165	0.00492	CbGbCtD
Diclofenac—CYP3A4—Thiotepa—hematologic cancer	0.00159	0.00476	CbGbCtD
Diclofenac—CYP2C9—Ifosfamide—hematologic cancer	0.00155	0.00464	CbGbCtD
Diclofenac—SLC22A8—Methotrexate—hematologic cancer	0.00153	0.00458	CbGbCtD
Diclofenac—CYP1A1—Dexamethasone—hematologic cancer	0.00151	0.00453	CbGbCtD
Diclofenac—CYP2C9—Imatinib—hematologic cancer	0.00148	0.00443	CbGbCtD
Diclofenac—ABCB1—Imatinib—hematologic cancer	0.00144	0.0043	CbGbCtD
Diclofenac—CXCR1—blood—hematologic cancer	0.00143	0.0479	CbGeAlD
Diclofenac—CYP2B6—Cisplatin—hematologic cancer	0.00143	0.00427	CbGbCtD
Diclofenac—CYP2E1—Etoposide—hematologic cancer	0.00142	0.00426	CbGbCtD
Diclofenac—CXCR1—bone marrow—hematologic cancer	0.00138	0.0463	CbGeAlD
Diclofenac—CYP2C9—Nilotinib—hematologic cancer	0.00135	0.00403	CbGbCtD
Diclofenac—CYP1A2—Dasatinib—hematologic cancer	0.00132	0.00395	CbGbCtD
Diclofenac—ABCB1—Nilotinib—hematologic cancer	0.00131	0.00391	CbGbCtD
Diclofenac—ABCB1—Vinorelbine—hematologic cancer	0.0013	0.00388	CbGbCtD
Diclofenac—CXCR1—lung—hematologic cancer	0.00125	0.042	CbGeAlD
Diclofenac—CYP3A4—Methoxsalen—hematologic cancer	0.00124	0.0037	CbGbCtD
Diclofenac—CYP3A4—Bortezomib—hematologic cancer	0.00118	0.00352	CbGbCtD
Diclofenac—CYP2C19—Prednisone—hematologic cancer	0.00117	0.00351	CbGbCtD
Diclofenac—CYP2E1—Dexamethasone—hematologic cancer	0.00117	0.0035	CbGbCtD
Diclofenac—ABCB1—Dasatinib—hematologic cancer	0.00116	0.00346	CbGbCtD
Diclofenac—CYP2B6—Dexamethasone—hematologic cancer	0.00115	0.00345	CbGbCtD
Diclofenac—ABCB1—Mitoxantrone—hematologic cancer	0.00114	0.00341	CbGbCtD
Diclofenac—CYP3A4—Daunorubicin—hematologic cancer	0.00113	0.00337	CbGbCtD
Diclofenac—SLC22A6—Methotrexate—hematologic cancer	0.00107	0.00319	CbGbCtD
Diclofenac—CYP2C8—Etoposide—hematologic cancer	0.00106	0.00318	CbGbCtD
Diclofenac—ABCB1—Betamethasone—hematologic cancer	0.00102	0.00304	CbGbCtD
Diclofenac—ABCB1—Gemcitabine—hematologic cancer	0.00101	0.00302	CbGbCtD
Diclofenac—ABCB1—Prednisolone—hematologic cancer	0.001	0.003	CbGbCtD
Diclofenac—CYP3A4—Cytarabine—hematologic cancer	0.000992	0.00297	CbGbCtD
Diclofenac—CYP3A4—Teniposide—hematologic cancer	0.000978	0.00293	CbGbCtD
Diclofenac—CYP2B6—Doxorubicin—hematologic cancer	0.000957	0.00286	CbGbCtD
Diclofenac—ABCB1—Prednisone—hematologic cancer	0.000948	0.00284	CbGbCtD
Diclofenac—ALB—Methotrexate—hematologic cancer	0.000909	0.00272	CbGbCtD
Diclofenac—CYP3A4—Ifosfamide—hematologic cancer	0.000902	0.0027	CbGbCtD
Diclofenac—ABCB1—Irinotecan—hematologic cancer	0.000898	0.00269	CbGbCtD
Diclofenac—CYP2C8—Dexamethasone—hematologic cancer	0.000874	0.00262	CbGbCtD
Diclofenac—CYP3A4—Imatinib—hematologic cancer	0.000862	0.00258	CbGbCtD
Diclofenac—CXCR1—lymph node—hematologic cancer	0.000858	0.0287	CbGeAlD
Diclofenac—CYP1A2—Etoposide—hematologic cancer	0.000823	0.00246	CbGbCtD
Diclofenac—CYP3A4—Ruxolitinib—hematologic cancer	0.000812	0.00243	CbGbCtD
Diclofenac—ABCB1—Vinblastine—hematologic cancer	0.000799	0.00239	CbGbCtD
Diclofenac—ABCB1—Vincristine—hematologic cancer	0.000785	0.00235	CbGbCtD
Diclofenac—CYP3A4—Nilotinib—hematologic cancer	0.000783	0.00234	CbGbCtD
Diclofenac—CYP3A4—Vinorelbine—hematologic cancer	0.000777	0.00232	CbGbCtD
Diclofenac—PLA2G2A—hematopoietic system—hematologic cancer	0.000774	0.0259	CbGeAlD
Diclofenac—CYP2C9—Cisplatin—hematologic cancer	0.000755	0.00226	CbGbCtD
Diclofenac—CYP2C19—Dexamethasone—hematologic cancer	0.000733	0.00219	CbGbCtD
Diclofenac—ABCB1—Cisplatin—hematologic cancer	0.000732	0.00219	CbGbCtD
Diclofenac—ABCB1—Etoposide—hematologic cancer	0.00072	0.00215	CbGbCtD
Diclofenac—KCNQ2—gonad—hematologic cancer	0.000715	0.0239	CbGeAlD
Diclofenac—CYP3A4—Triamcinolone—hematologic cancer	0.00071	0.00213	CbGbCtD
Diclofenac—ASIC1—testis—hematologic cancer	0.000704	0.0236	CbGeAlD
Diclofenac—CYP3A4—Dasatinib—hematologic cancer	0.000692	0.00207	CbGbCtD
Diclofenac—CYP3A4—Mitoxantrone—hematologic cancer	0.000684	0.00205	CbGbCtD
Diclofenac—CYP2C9—Dexamethasone—hematologic cancer	0.00061	0.00182	CbGbCtD
Diclofenac—CYP3A4—Betamethasone—hematologic cancer	0.000609	0.00182	CbGbCtD
Diclofenac—CYP3A4—Prednisolone—hematologic cancer	0.000601	0.0018	CbGbCtD
Diclofenac—KCNQ3—lung—hematologic cancer	0.000593	0.0199	CbGeAlD
Diclofenac—ABCB1—Dexamethasone—hematologic cancer	0.000592	0.00177	CbGbCtD
Diclofenac—TTR—hematopoietic system—hematologic cancer	0.000584	0.0196	CbGeAlD
Diclofenac—CYP3A4—Prednisone—hematologic cancer	0.000568	0.0017	CbGbCtD
Diclofenac—UGT1A1—hematopoietic system—hematologic cancer	0.000554	0.0185	CbGeAlD
Diclofenac—CYP3A4—Irinotecan—hematologic cancer	0.000538	0.00161	CbGbCtD
Diclofenac—ALOX5—hematopoietic system—hematologic cancer	0.000529	0.0177	CbGeAlD
Diclofenac—KCNQ2—testis—hematologic cancer	0.000515	0.0172	CbGeAlD
Diclofenac—PLA2G2A—blood—hematologic cancer	0.000513	0.0172	CbGeAlD
Diclofenac—ASIC1—lymph node—hematologic cancer	0.00051	0.0171	CbGeAlD
Diclofenac—CXCL8—blood—hematologic cancer	0.000508	0.017	CbGeAlD
Diclofenac—CXCL8—bone marrow—hematologic cancer	0.000491	0.0164	CbGeAlD
Diclofenac—ABCB1—Doxorubicin—hematologic cancer	0.000491	0.00147	CbGbCtD
Diclofenac—CYP3A4—Vinblastine—hematologic cancer	0.000479	0.00143	CbGbCtD
Diclofenac—ABCB1—Methotrexate—hematologic cancer	0.000475	0.00142	CbGbCtD
Diclofenac—CYP3A4—Vincristine—hematologic cancer	0.000471	0.00141	CbGbCtD
Diclofenac—PLA2G2A—lung—hematologic cancer	0.000449	0.0151	CbGeAlD
Diclofenac—CXCL8—lung—hematologic cancer	0.000445	0.0149	CbGeAlD
Diclofenac—CYP3A4—Etoposide—hematologic cancer	0.000431	0.00129	CbGbCtD
Diclofenac—PLA2G2A—testis—hematologic cancer	0.000424	0.0142	CbGeAlD
Diclofenac—CXCL8—testis—hematologic cancer	0.00042	0.0141	CbGeAlD
Diclofenac—TTR—blood—hematologic cancer	0.000387	0.013	CbGeAlD
Diclofenac—TTR—bone marrow—hematologic cancer	0.000375	0.0125	CbGeAlD
Diclofenac—UGT1A1—blood—hematologic cancer	0.000367	0.0123	CbGeAlD
Diclofenac—Meclofenamic acid—ALOX5—hematologic cancer	0.000362	0.57	CrCbGaD
Diclofenac—ABCC4—hematopoietic system—hematologic cancer	0.000361	0.0121	CbGeAlD
Diclofenac—SLCO1C1—testis—hematologic cancer	0.000358	0.012	CbGeAlD
Diclofenac—SLC22A8—hematopoietic system—hematologic cancer	0.000358	0.012	CbGeAlD
Diclofenac—UGT2B7—testis—hematologic cancer	0.000357	0.012	CbGeAlD
Diclofenac—CYP3A4—Dexamethasone—hematologic cancer	0.000354	0.00106	CbGbCtD
Diclofenac—ALOX5—blood—hematologic cancer	0.000351	0.0117	CbGeAlD
Diclofenac—ALOX5—bone marrow—hematologic cancer	0.000339	0.0114	CbGeAlD
Diclofenac—TTR—lung—hematologic cancer	0.000339	0.0114	CbGeAlD
Diclofenac—SCN4A—testis—hematologic cancer	0.000329	0.011	CbGeAlD
Diclofenac—TTR—testis—hematologic cancer	0.00032	0.0107	CbGeAlD
Diclofenac—ALOX5—lung—hematologic cancer	0.000308	0.0103	CbGeAlD
Diclofenac—PLA2G2A—lymph node—hematologic cancer	0.000307	0.0103	CbGeAlD
Diclofenac—CXCL8—lymph node—hematologic cancer	0.000304	0.0102	CbGeAlD
Diclofenac—CYP2C19—hematopoietic system—hematologic cancer	0.0003	0.0101	CbGeAlD
Diclofenac—CYP3A4—Doxorubicin—hematologic cancer	0.000294	0.00088	CbGbCtD
Diclofenac—ALOX5—testis—hematologic cancer	0.00029	0.00971	CbGeAlD
Diclofenac—CYP2C8—hematopoietic system—hematologic cancer	0.000262	0.00877	CbGeAlD
Diclofenac—SLCO1C1—lymph node—hematologic cancer	0.00026	0.00869	CbGeAlD
Diclofenac—CYP1A2—hematopoietic system—hematologic cancer	0.000245	0.00821	CbGeAlD
Diclofenac—CYP1A1—hematopoietic system—hematologic cancer	0.000242	0.0081	CbGeAlD
Diclofenac—ABCC4—blood—hematologic cancer	0.000239	0.00801	CbGeAlD
Diclofenac—SLC22A8—blood—hematologic cancer	0.000237	0.00794	CbGeAlD
Diclofenac—CYP2B6—hematopoietic system—hematologic cancer	0.000235	0.00787	CbGeAlD
Diclofenac—CYP2C9—hematopoietic system—hematologic cancer	0.000233	0.00779	CbGeAlD
Diclofenac—ABCC4—bone marrow—hematologic cancer	0.000231	0.00775	CbGeAlD
Diclofenac—CYP2E1—hematopoietic system—hematologic cancer	0.000221	0.00739	CbGeAlD
Diclofenac—PTGS1—hematopoietic system—hematologic cancer	0.000213	0.00712	CbGeAlD
Diclofenac—Clonidine—SLC22A1—hematologic cancer	0.000212	0.333	CrCbGaD
Diclofenac—ALOX5—lymph node—hematologic cancer	0.00021	0.00704	CbGeAlD
Diclofenac—ABCC4—lung—hematologic cancer	0.00021	0.00702	CbGeAlD
Diclofenac—ALB—testis—hematologic cancer	0.000204	0.00684	CbGeAlD
Diclofenac—ABCC1—blood—hematologic cancer	0.000204	0.00683	CbGeAlD
Diclofenac—PTGS2—hematopoietic system—hematologic cancer	0.000203	0.0068	CbGeAlD
Diclofenac—CYP2C19—blood—hematologic cancer	0.000199	0.00666	CbGeAlD
Diclofenac—ABCC4—testis—hematologic cancer	0.000198	0.00662	CbGeAlD
Diclofenac—ABCC1—lung—hematologic cancer	0.000179	0.00599	CbGeAlD
Diclofenac—CYP2B6—gonad—hematologic cancer	0.000179	0.00598	CbGeAlD
Diclofenac—CYP3A4—hematopoietic system—hematologic cancer	0.000178	0.00594	CbGeAlD
Diclofenac—CYP2C8—blood—hematologic cancer	0.000174	0.00581	CbGeAlD
Diclofenac—ABCC1—testis—hematologic cancer	0.000169	0.00565	CbGeAlD
Diclofenac—CYP1A2—blood—hematologic cancer	0.000162	0.00544	CbGeAlD
Diclofenac—CYP1A1—blood—hematologic cancer	0.00016	0.00537	CbGeAlD
Diclofenac—CYP2B6—blood—hematologic cancer	0.000156	0.00521	CbGeAlD
Diclofenac—CYP2C9—blood—hematologic cancer	0.000154	0.00516	CbGeAlD
Diclofenac—ALB—lymph node—hematologic cancer	0.000148	0.00496	CbGeAlD
Diclofenac—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	0.000147	0.209	CbGdCrCtD
Diclofenac—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	0.000147	0.209	CbGdCrCtD
Diclofenac—CYP2E1—blood—hematologic cancer	0.000146	0.00489	CbGeAlD
Diclofenac—CYP2C8—testis—hematologic cancer	0.000144	0.00481	CbGeAlD
Diclofenac—ABCC4—lymph node—hematologic cancer	0.000143	0.0048	CbGeAlD
Diclofenac—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	0.000143	0.205	CbGdCrCtD
Diclofenac—CYP1A2—lung—hematologic cancer	0.000142	0.00477	CbGeAlD
Diclofenac—PTGS1—blood—hematologic cancer	0.000141	0.00471	CbGeAlD
Diclofenac—CYP1A1—lung—hematologic cancer	0.00014	0.0047	CbGeAlD
Diclofenac—CYP2B6—lung—hematologic cancer	0.000137	0.00457	CbGeAlD
Diclofenac—PTGS2—blood—hematologic cancer	0.000135	0.00451	CbGeAlD
Diclofenac—PTGS2—bone marrow—hematologic cancer	0.00013	0.00436	CbGeAlD
Diclofenac—CYP2B6—testis—hematologic cancer	0.000129	0.00431	CbGeAlD
Diclofenac—CYP2E1—lung—hematologic cancer	0.000128	0.00429	CbGeAlD
Diclofenac—ABCB1—hematopoietic system—hematologic cancer	0.000126	0.00421	CbGeAlD
Diclofenac—PTGS1—lung—hematologic cancer	0.000123	0.00413	CbGeAlD
Diclofenac—ABCC1—lymph node—hematologic cancer	0.000122	0.00409	CbGeAlD
Diclofenac—CYP2E1—testis—hematologic cancer	0.000121	0.00405	CbGeAlD
Diclofenac—PTGS2—lung—hematologic cancer	0.000118	0.00395	CbGeAlD
Diclofenac—CYP3A4—blood—hematologic cancer	0.000118	0.00394	CbGeAlD
Diclofenac—PTGS1—testis—hematologic cancer	0.000116	0.0039	CbGeAlD
Diclofenac—CYP1A1—lymph node—hematologic cancer	9.61e-05	0.00322	CbGeAlD
Diclofenac—ABCB1—gonad—hematologic cancer	9.55e-05	0.0032	CbGeAlD
Diclofenac—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	8.84e-05	0.126	CbGdCrCtD
Diclofenac—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	8.84e-05	0.126	CbGdCrCtD
Diclofenac—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	8.64e-05	0.124	CbGdCrCtD
Diclofenac—PTGS1—lymph node—hematologic cancer	8.44e-05	0.00283	CbGeAlD
Diclofenac—ABCB1—blood—hematologic cancer	8.32e-05	0.00279	CbGeAlD
Diclofenac—PTGS2—lymph node—hematologic cancer	8.07e-05	0.0027	CbGeAlD
Diclofenac—ABCB1—bone marrow—hematologic cancer	8.05e-05	0.0027	CbGeAlD
Diclofenac—ABCB1—lung—hematologic cancer	7.3e-05	0.00244	CbGeAlD
Diclofenac—ABCB1—testis—hematologic cancer	6.89e-05	0.00231	CbGeAlD
Diclofenac—Clonidine—ABCB1—hematologic cancer	6.15e-05	0.0968	CrCbGaD
Diclofenac—ABCB1—lymph node—hematologic cancer	4.99e-05	0.00167	CbGeAlD
Diclofenac—Flatulence—Epirubicin—hematologic cancer	5.89e-06	4.55e-05	CcSEcCtD
Diclofenac—Tension—Epirubicin—hematologic cancer	5.86e-06	4.53e-05	CcSEcCtD
Diclofenac—Gastrointestinal pain—Dexamethasone—hematologic cancer	5.85e-06	4.52e-05	CcSEcCtD
Diclofenac—Gastrointestinal pain—Betamethasone—hematologic cancer	5.85e-06	4.52e-05	CcSEcCtD
Diclofenac—Dysgeusia—Epirubicin—hematologic cancer	5.85e-06	4.52e-05	CcSEcCtD
Diclofenac—Hypersensitivity—Triamcinolone—hematologic cancer	5.81e-06	4.49e-05	CcSEcCtD
Diclofenac—Nervousness—Epirubicin—hematologic cancer	5.8e-06	4.48e-05	CcSEcCtD
Diclofenac—Back pain—Epirubicin—hematologic cancer	5.78e-06	4.46e-05	CcSEcCtD
Diclofenac—Angiopathy—Doxorubicin—hematologic cancer	5.76e-06	4.45e-05	CcSEcCtD
Diclofenac—Malaise—Methotrexate—hematologic cancer	5.76e-06	4.45e-05	CcSEcCtD
Diclofenac—Dizziness—Etoposide—hematologic cancer	5.75e-06	4.44e-05	CcSEcCtD
Diclofenac—Muscle spasms—Epirubicin—hematologic cancer	5.74e-06	4.44e-05	CcSEcCtD
Diclofenac—Immune system disorder—Doxorubicin—hematologic cancer	5.74e-06	4.43e-05	CcSEcCtD
Diclofenac—Vertigo—Methotrexate—hematologic cancer	5.74e-06	4.43e-05	CcSEcCtD
Diclofenac—Mediastinal disorder—Doxorubicin—hematologic cancer	5.72e-06	4.42e-05	CcSEcCtD
Diclofenac—Leukopenia—Methotrexate—hematologic cancer	5.71e-06	4.41e-05	CcSEcCtD
Diclofenac—Chills—Doxorubicin—hematologic cancer	5.7e-06	4.4e-05	CcSEcCtD
Diclofenac—Urticaria—Dexamethasone—hematologic cancer	5.69e-06	4.39e-05	CcSEcCtD
Diclofenac—Urticaria—Betamethasone—hematologic cancer	5.69e-06	4.39e-05	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Prednisone—hematologic cancer	5.68e-06	4.39e-05	CcSEcCtD
Diclofenac—Dizziness—Prednisolone—hematologic cancer	5.67e-06	4.38e-05	CcSEcCtD
Diclofenac—Arrhythmia—Doxorubicin—hematologic cancer	5.67e-06	4.38e-05	CcSEcCtD
Diclofenac—Asthenia—Triamcinolone—hematologic cancer	5.66e-06	4.37e-05	CcSEcCtD
Diclofenac—Body temperature increased—Betamethasone—hematologic cancer	5.66e-06	4.37e-05	CcSEcCtD
Diclofenac—Abdominal pain—Dexamethasone—hematologic cancer	5.66e-06	4.37e-05	CcSEcCtD
Diclofenac—Abdominal pain—Betamethasone—hematologic cancer	5.66e-06	4.37e-05	CcSEcCtD
Diclofenac—Body temperature increased—Dexamethasone—hematologic cancer	5.66e-06	4.37e-05	CcSEcCtD
Diclofenac—Nausea—Cisplatin—hematologic cancer	5.64e-06	4.36e-05	CcSEcCtD
Diclofenac—Insomnia—Prednisone—hematologic cancer	5.64e-06	4.36e-05	CcSEcCtD
Diclofenac—Vision blurred—Epirubicin—hematologic cancer	5.63e-06	4.35e-05	CcSEcCtD
Diclofenac—Alopecia—Doxorubicin—hematologic cancer	5.61e-06	4.34e-05	CcSEcCtD
Diclofenac—Paraesthesia—Prednisone—hematologic cancer	5.6e-06	4.33e-05	CcSEcCtD
Diclofenac—Pruritus—Triamcinolone—hematologic cancer	5.58e-06	4.31e-05	CcSEcCtD
Diclofenac—Cough—Methotrexate—hematologic cancer	5.57e-06	4.3e-05	CcSEcCtD
Diclofenac—Mental disorder—Doxorubicin—hematologic cancer	5.56e-06	4.3e-05	CcSEcCtD
Diclofenac—Ill-defined disorder—Epirubicin—hematologic cancer	5.54e-06	4.28e-05	CcSEcCtD
Diclofenac—Convulsion—Methotrexate—hematologic cancer	5.53e-06	4.27e-05	CcSEcCtD
Diclofenac—Vomiting—Etoposide—hematologic cancer	5.53e-06	4.27e-05	CcSEcCtD
Diclofenac—Erythema—Doxorubicin—hematologic cancer	5.53e-06	4.27e-05	CcSEcCtD
Diclofenac—Malnutrition—Doxorubicin—hematologic cancer	5.53e-06	4.27e-05	CcSEcCtD
Diclofenac—Anaemia—Epirubicin—hematologic cancer	5.52e-06	4.27e-05	CcSEcCtD
Diclofenac—Agitation—Epirubicin—hematologic cancer	5.49e-06	4.24e-05	CcSEcCtD
Diclofenac—Dyspepsia—Prednisone—hematologic cancer	5.49e-06	4.24e-05	CcSEcCtD
Diclofenac—Rash—Etoposide—hematologic cancer	5.48e-06	4.24e-05	CcSEcCtD
Diclofenac—Dermatitis—Etoposide—hematologic cancer	5.48e-06	4.23e-05	CcSEcCtD
Diclofenac—Headache—Etoposide—hematologic cancer	5.45e-06	4.21e-05	CcSEcCtD
Diclofenac—Flatulence—Doxorubicin—hematologic cancer	5.45e-06	4.21e-05	CcSEcCtD
Diclofenac—Arthralgia—Methotrexate—hematologic cancer	5.43e-06	4.2e-05	CcSEcCtD
Diclofenac—Chest pain—Methotrexate—hematologic cancer	5.43e-06	4.2e-05	CcSEcCtD
Diclofenac—Myalgia—Methotrexate—hematologic cancer	5.43e-06	4.2e-05	CcSEcCtD
Diclofenac—Tension—Doxorubicin—hematologic cancer	5.42e-06	4.19e-05	CcSEcCtD
Diclofenac—Decreased appetite—Prednisone—hematologic cancer	5.42e-06	4.19e-05	CcSEcCtD
Diclofenac—Dysgeusia—Doxorubicin—hematologic cancer	5.41e-06	4.18e-05	CcSEcCtD
Diclofenac—Rash—Prednisolone—hematologic cancer	5.41e-06	4.18e-05	CcSEcCtD
Diclofenac—Dermatitis—Prednisolone—hematologic cancer	5.4e-06	4.18e-05	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	5.4e-06	4.17e-05	CcSEcCtD
Diclofenac—Malaise—Epirubicin—hematologic cancer	5.39e-06	4.16e-05	CcSEcCtD
Diclofenac—Fatigue—Prednisone—hematologic cancer	5.37e-06	4.15e-05	CcSEcCtD
Diclofenac—Headache—Prednisolone—hematologic cancer	5.37e-06	4.15e-05	CcSEcCtD
Diclofenac—Discomfort—Methotrexate—hematologic cancer	5.37e-06	4.15e-05	CcSEcCtD
Diclofenac—Nervousness—Doxorubicin—hematologic cancer	5.37e-06	4.15e-05	CcSEcCtD
Diclofenac—Vertigo—Epirubicin—hematologic cancer	5.37e-06	4.15e-05	CcSEcCtD
Diclofenac—Syncope—Epirubicin—hematologic cancer	5.36e-06	4.14e-05	CcSEcCtD
Diclofenac—Leukopenia—Epirubicin—hematologic cancer	5.35e-06	4.13e-05	CcSEcCtD
Diclofenac—Back pain—Doxorubicin—hematologic cancer	5.35e-06	4.13e-05	CcSEcCtD
Diclofenac—Constipation—Prednisone—hematologic cancer	5.33e-06	4.12e-05	CcSEcCtD
Diclofenac—Muscle spasms—Doxorubicin—hematologic cancer	5.31e-06	4.11e-05	CcSEcCtD
Diclofenac—Palpitations—Epirubicin—hematologic cancer	5.28e-06	4.08e-05	CcSEcCtD
Diclofenac—Confusional state—Methotrexate—hematologic cancer	5.25e-06	4.06e-05	CcSEcCtD
Diclofenac—Loss of consciousness—Epirubicin—hematologic cancer	5.25e-06	4.06e-05	CcSEcCtD
Diclofenac—Dizziness—Triamcinolone—hematologic cancer	5.22e-06	4.03e-05	CcSEcCtD
Diclofenac—Cough—Epirubicin—hematologic cancer	5.21e-06	4.03e-05	CcSEcCtD
Diclofenac—Anaphylactic shock—Methotrexate—hematologic cancer	5.21e-06	4.03e-05	CcSEcCtD
Diclofenac—Vision blurred—Doxorubicin—hematologic cancer	5.21e-06	4.02e-05	CcSEcCtD
Diclofenac—Convulsion—Epirubicin—hematologic cancer	5.18e-06	4e-05	CcSEcCtD
Diclofenac—Infection—Methotrexate—hematologic cancer	5.18e-06	4e-05	CcSEcCtD
Diclofenac—Nausea—Etoposide—hematologic cancer	5.17e-06	3.99e-05	CcSEcCtD
Diclofenac—Hypertension—Epirubicin—hematologic cancer	5.16e-06	3.99e-05	CcSEcCtD
Diclofenac—Feeling abnormal—Prednisone—hematologic cancer	5.14e-06	3.97e-05	CcSEcCtD
Diclofenac—Asthenia—Dexamethasone—hematologic cancer	5.14e-06	3.97e-05	CcSEcCtD
Diclofenac—Asthenia—Betamethasone—hematologic cancer	5.14e-06	3.97e-05	CcSEcCtD
Diclofenac—Ill-defined disorder—Doxorubicin—hematologic cancer	5.13e-06	3.96e-05	CcSEcCtD
Diclofenac—Nervous system disorder—Methotrexate—hematologic cancer	5.11e-06	3.95e-05	CcSEcCtD
Diclofenac—Anaemia—Doxorubicin—hematologic cancer	5.11e-06	3.95e-05	CcSEcCtD
Diclofenac—Thrombocytopenia—Methotrexate—hematologic cancer	5.1e-06	3.94e-05	CcSEcCtD
Diclofenac—Gastrointestinal pain—Prednisone—hematologic cancer	5.1e-06	3.94e-05	CcSEcCtD
Diclofenac—Nausea—Prednisolone—hematologic cancer	5.1e-06	3.94e-05	CcSEcCtD
Diclofenac—Chest pain—Epirubicin—hematologic cancer	5.09e-06	3.93e-05	CcSEcCtD
Diclofenac—Myalgia—Epirubicin—hematologic cancer	5.09e-06	3.93e-05	CcSEcCtD
Diclofenac—Arthralgia—Epirubicin—hematologic cancer	5.09e-06	3.93e-05	CcSEcCtD
Diclofenac—Agitation—Doxorubicin—hematologic cancer	5.08e-06	3.92e-05	CcSEcCtD
Diclofenac—Anxiety—Epirubicin—hematologic cancer	5.07e-06	3.92e-05	CcSEcCtD
Diclofenac—Pruritus—Dexamethasone—hematologic cancer	5.06e-06	3.91e-05	CcSEcCtD
Diclofenac—Pruritus—Betamethasone—hematologic cancer	5.06e-06	3.91e-05	CcSEcCtD
Diclofenac—Skin disorder—Methotrexate—hematologic cancer	5.06e-06	3.91e-05	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	5.05e-06	3.9e-05	CcSEcCtD
Diclofenac—Hyperhidrosis—Methotrexate—hematologic cancer	5.04e-06	3.89e-05	CcSEcCtD
Diclofenac—Discomfort—Epirubicin—hematologic cancer	5.03e-06	3.88e-05	CcSEcCtD
Diclofenac—Vomiting—Triamcinolone—hematologic cancer	5.02e-06	3.88e-05	CcSEcCtD
Diclofenac—Malaise—Doxorubicin—hematologic cancer	4.98e-06	3.85e-05	CcSEcCtD
Diclofenac—Rash—Triamcinolone—hematologic cancer	4.97e-06	3.84e-05	CcSEcCtD
Diclofenac—Dry mouth—Epirubicin—hematologic cancer	4.97e-06	3.84e-05	CcSEcCtD
Diclofenac—Dermatitis—Triamcinolone—hematologic cancer	4.97e-06	3.84e-05	CcSEcCtD
Diclofenac—Vertigo—Doxorubicin—hematologic cancer	4.97e-06	3.84e-05	CcSEcCtD
Diclofenac—Anorexia—Methotrexate—hematologic cancer	4.97e-06	3.84e-05	CcSEcCtD
Diclofenac—Syncope—Doxorubicin—hematologic cancer	4.96e-06	3.83e-05	CcSEcCtD
Diclofenac—Urticaria—Prednisone—hematologic cancer	4.95e-06	3.83e-05	CcSEcCtD
Diclofenac—Leukopenia—Doxorubicin—hematologic cancer	4.95e-06	3.82e-05	CcSEcCtD
Diclofenac—Headache—Triamcinolone—hematologic cancer	4.94e-06	3.82e-05	CcSEcCtD
Diclofenac—Abdominal pain—Prednisone—hematologic cancer	4.93e-06	3.81e-05	CcSEcCtD
Diclofenac—Body temperature increased—Prednisone—hematologic cancer	4.93e-06	3.81e-05	CcSEcCtD
Diclofenac—Confusional state—Epirubicin—hematologic cancer	4.92e-06	3.8e-05	CcSEcCtD
Diclofenac—Diarrhoea—Betamethasone—hematologic cancer	4.9e-06	3.78e-05	CcSEcCtD
Diclofenac—Diarrhoea—Dexamethasone—hematologic cancer	4.9e-06	3.78e-05	CcSEcCtD
Diclofenac—Palpitations—Doxorubicin—hematologic cancer	4.88e-06	3.77e-05	CcSEcCtD
Diclofenac—Anaphylactic shock—Epirubicin—hematologic cancer	4.88e-06	3.77e-05	CcSEcCtD
Diclofenac—Oedema—Epirubicin—hematologic cancer	4.88e-06	3.77e-05	CcSEcCtD
Diclofenac—Hypotension—Methotrexate—hematologic cancer	4.87e-06	3.76e-05	CcSEcCtD
Diclofenac—Loss of consciousness—Doxorubicin—hematologic cancer	4.86e-06	3.75e-05	CcSEcCtD
Diclofenac—Infection—Epirubicin—hematologic cancer	4.84e-06	3.74e-05	CcSEcCtD
Diclofenac—Cough—Doxorubicin—hematologic cancer	4.82e-06	3.73e-05	CcSEcCtD
Diclofenac—Shock—Epirubicin—hematologic cancer	4.8e-06	3.71e-05	CcSEcCtD
Diclofenac—Convulsion—Doxorubicin—hematologic cancer	4.79e-06	3.7e-05	CcSEcCtD
Diclofenac—Nervous system disorder—Epirubicin—hematologic cancer	4.78e-06	3.69e-05	CcSEcCtD
Diclofenac—Thrombocytopenia—Epirubicin—hematologic cancer	4.77e-06	3.69e-05	CcSEcCtD
Diclofenac—Hypertension—Doxorubicin—hematologic cancer	4.77e-06	3.69e-05	CcSEcCtD
Diclofenac—Tachycardia—Epirubicin—hematologic cancer	4.76e-06	3.68e-05	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Methotrexate—hematologic cancer	4.75e-06	3.67e-05	CcSEcCtD
Diclofenac—Skin disorder—Epirubicin—hematologic cancer	4.74e-06	3.66e-05	CcSEcCtD
Diclofenac—Dizziness—Dexamethasone—hematologic cancer	4.73e-06	3.66e-05	CcSEcCtD
Diclofenac—Dizziness—Betamethasone—hematologic cancer	4.73e-06	3.66e-05	CcSEcCtD
Diclofenac—Hyperhidrosis—Epirubicin—hematologic cancer	4.71e-06	3.64e-05	CcSEcCtD
Diclofenac—Insomnia—Methotrexate—hematologic cancer	4.71e-06	3.64e-05	CcSEcCtD
Diclofenac—Chest pain—Doxorubicin—hematologic cancer	4.71e-06	3.64e-05	CcSEcCtD
Diclofenac—Myalgia—Doxorubicin—hematologic cancer	4.71e-06	3.64e-05	CcSEcCtD
Diclofenac—Arthralgia—Doxorubicin—hematologic cancer	4.71e-06	3.64e-05	CcSEcCtD
Diclofenac—Anxiety—Doxorubicin—hematologic cancer	4.69e-06	3.62e-05	CcSEcCtD
Diclofenac—Nausea—Triamcinolone—hematologic cancer	4.69e-06	3.62e-05	CcSEcCtD
Diclofenac—Paraesthesia—Methotrexate—hematologic cancer	4.68e-06	3.61e-05	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	4.67e-06	3.61e-05	CcSEcCtD
Diclofenac—Discomfort—Doxorubicin—hematologic cancer	4.65e-06	3.59e-05	CcSEcCtD
Diclofenac—Anorexia—Epirubicin—hematologic cancer	4.65e-06	3.59e-05	CcSEcCtD
Diclofenac—Dyspnoea—Methotrexate—hematologic cancer	4.64e-06	3.59e-05	CcSEcCtD
Diclofenac—Somnolence—Methotrexate—hematologic cancer	4.63e-06	3.58e-05	CcSEcCtD
Diclofenac—Dry mouth—Doxorubicin—hematologic cancer	4.6e-06	3.56e-05	CcSEcCtD
Diclofenac—Hypersensitivity—Prednisone—hematologic cancer	4.59e-06	3.55e-05	CcSEcCtD
Diclofenac—Dyspepsia—Methotrexate—hematologic cancer	4.59e-06	3.54e-05	CcSEcCtD
Diclofenac—Hypotension—Epirubicin—hematologic cancer	4.56e-06	3.52e-05	CcSEcCtD
Diclofenac—Vomiting—Betamethasone—hematologic cancer	4.55e-06	3.52e-05	CcSEcCtD
Diclofenac—Vomiting—Dexamethasone—hematologic cancer	4.55e-06	3.52e-05	CcSEcCtD
Diclofenac—Confusional state—Doxorubicin—hematologic cancer	4.55e-06	3.51e-05	CcSEcCtD
Diclofenac—Decreased appetite—Methotrexate—hematologic cancer	4.53e-06	3.5e-05	CcSEcCtD
Diclofenac—Rash—Betamethasone—hematologic cancer	4.51e-06	3.49e-05	CcSEcCtD
Diclofenac—Rash—Dexamethasone—hematologic cancer	4.51e-06	3.49e-05	CcSEcCtD
Diclofenac—Anaphylactic shock—Doxorubicin—hematologic cancer	4.51e-06	3.49e-05	CcSEcCtD
Diclofenac—Oedema—Doxorubicin—hematologic cancer	4.51e-06	3.49e-05	CcSEcCtD
Diclofenac—Dermatitis—Betamethasone—hematologic cancer	4.51e-06	3.48e-05	CcSEcCtD
Diclofenac—Dermatitis—Dexamethasone—hematologic cancer	4.51e-06	3.48e-05	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Methotrexate—hematologic cancer	4.5e-06	3.48e-05	CcSEcCtD
Diclofenac—Fatigue—Methotrexate—hematologic cancer	4.49e-06	3.47e-05	CcSEcCtD
Diclofenac—Headache—Dexamethasone—hematologic cancer	4.48e-06	3.46e-05	CcSEcCtD
Diclofenac—Headache—Betamethasone—hematologic cancer	4.48e-06	3.46e-05	CcSEcCtD
Diclofenac—Infection—Doxorubicin—hematologic cancer	4.48e-06	3.46e-05	CcSEcCtD
Diclofenac—Asthenia—Prednisone—hematologic cancer	4.47e-06	3.46e-05	CcSEcCtD
Diclofenac—Pain—Methotrexate—hematologic cancer	4.46e-06	3.44e-05	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Epirubicin—hematologic cancer	4.44e-06	3.43e-05	CcSEcCtD
Diclofenac—Shock—Doxorubicin—hematologic cancer	4.44e-06	3.43e-05	CcSEcCtD
Diclofenac—Nervous system disorder—Doxorubicin—hematologic cancer	4.42e-06	3.42e-05	CcSEcCtD
Diclofenac—Thrombocytopenia—Doxorubicin—hematologic cancer	4.42e-06	3.41e-05	CcSEcCtD
Diclofenac—Pruritus—Prednisone—hematologic cancer	4.41e-06	3.41e-05	CcSEcCtD
Diclofenac—Insomnia—Epirubicin—hematologic cancer	4.41e-06	3.41e-05	CcSEcCtD
Diclofenac—Tachycardia—Doxorubicin—hematologic cancer	4.4e-06	3.4e-05	CcSEcCtD
Diclofenac—Skin disorder—Doxorubicin—hematologic cancer	4.38e-06	3.39e-05	CcSEcCtD
Diclofenac—Paraesthesia—Epirubicin—hematologic cancer	4.38e-06	3.38e-05	CcSEcCtD
Diclofenac—Hyperhidrosis—Doxorubicin—hematologic cancer	4.36e-06	3.37e-05	CcSEcCtD
Diclofenac—Dyspnoea—Epirubicin—hematologic cancer	4.35e-06	3.36e-05	CcSEcCtD
Diclofenac—Somnolence—Epirubicin—hematologic cancer	4.33e-06	3.35e-05	CcSEcCtD
Diclofenac—Anorexia—Doxorubicin—hematologic cancer	4.3e-06	3.32e-05	CcSEcCtD
Diclofenac—Feeling abnormal—Methotrexate—hematologic cancer	4.29e-06	3.32e-05	CcSEcCtD
Diclofenac—Dyspepsia—Epirubicin—hematologic cancer	4.29e-06	3.32e-05	CcSEcCtD
Diclofenac—Diarrhoea—Prednisone—hematologic cancer	4.27e-06	3.3e-05	CcSEcCtD
Diclofenac—Gastrointestinal pain—Methotrexate—hematologic cancer	4.26e-06	3.29e-05	CcSEcCtD
Diclofenac—Nausea—Betamethasone—hematologic cancer	4.25e-06	3.29e-05	CcSEcCtD
Diclofenac—Nausea—Dexamethasone—hematologic cancer	4.25e-06	3.29e-05	CcSEcCtD
Diclofenac—Decreased appetite—Epirubicin—hematologic cancer	4.24e-06	3.27e-05	CcSEcCtD
Diclofenac—Hypotension—Doxorubicin—hematologic cancer	4.22e-06	3.26e-05	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Epirubicin—hematologic cancer	4.21e-06	3.25e-05	CcSEcCtD
Diclofenac—Fatigue—Epirubicin—hematologic cancer	4.2e-06	3.25e-05	CcSEcCtD
Diclofenac—Pain—Epirubicin—hematologic cancer	4.17e-06	3.22e-05	CcSEcCtD
Diclofenac—Constipation—Epirubicin—hematologic cancer	4.17e-06	3.22e-05	CcSEcCtD
Diclofenac—Urticaria—Methotrexate—hematologic cancer	4.14e-06	3.2e-05	CcSEcCtD
Diclofenac—Dizziness—Prednisone—hematologic cancer	4.12e-06	3.19e-05	CcSEcCtD
Diclofenac—Body temperature increased—Methotrexate—hematologic cancer	4.12e-06	3.18e-05	CcSEcCtD
Diclofenac—Abdominal pain—Methotrexate—hematologic cancer	4.12e-06	3.18e-05	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	4.11e-06	3.18e-05	CcSEcCtD
Diclofenac—Insomnia—Doxorubicin—hematologic cancer	4.08e-06	3.15e-05	CcSEcCtD
Diclofenac—Paraesthesia—Doxorubicin—hematologic cancer	4.05e-06	3.13e-05	CcSEcCtD
Diclofenac—Dyspnoea—Doxorubicin—hematologic cancer	4.02e-06	3.11e-05	CcSEcCtD
Diclofenac—Feeling abnormal—Epirubicin—hematologic cancer	4.02e-06	3.1e-05	CcSEcCtD
Diclofenac—Somnolence—Doxorubicin—hematologic cancer	4.01e-06	3.1e-05	CcSEcCtD
Diclofenac—Gastrointestinal pain—Epirubicin—hematologic cancer	3.99e-06	3.08e-05	CcSEcCtD
Diclofenac—Dyspepsia—Doxorubicin—hematologic cancer	3.97e-06	3.07e-05	CcSEcCtD
Diclofenac—Vomiting—Prednisone—hematologic cancer	3.96e-06	3.06e-05	CcSEcCtD
Diclofenac—Rash—Prednisone—hematologic cancer	3.93e-06	3.04e-05	CcSEcCtD
Diclofenac—Dermatitis—Prednisone—hematologic cancer	3.93e-06	3.03e-05	CcSEcCtD
Diclofenac—Decreased appetite—Doxorubicin—hematologic cancer	3.92e-06	3.03e-05	CcSEcCtD
Diclofenac—Headache—Prednisone—hematologic cancer	3.91e-06	3.02e-05	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.89e-06	3.01e-05	CcSEcCtD
Diclofenac—Fatigue—Doxorubicin—hematologic cancer	3.89e-06	3.01e-05	CcSEcCtD
Diclofenac—Urticaria—Epirubicin—hematologic cancer	3.87e-06	2.99e-05	CcSEcCtD
Diclofenac—Pain—Doxorubicin—hematologic cancer	3.86e-06	2.98e-05	CcSEcCtD
Diclofenac—Constipation—Doxorubicin—hematologic cancer	3.86e-06	2.98e-05	CcSEcCtD
Diclofenac—Abdominal pain—Epirubicin—hematologic cancer	3.85e-06	2.98e-05	CcSEcCtD
Diclofenac—Body temperature increased—Epirubicin—hematologic cancer	3.85e-06	2.98e-05	CcSEcCtD
Diclofenac—Hypersensitivity—Methotrexate—hematologic cancer	3.84e-06	2.97e-05	CcSEcCtD
Diclofenac—Asthenia—Methotrexate—hematologic cancer	3.74e-06	2.89e-05	CcSEcCtD
Diclofenac—Feeling abnormal—Doxorubicin—hematologic cancer	3.72e-06	2.87e-05	CcSEcCtD
Diclofenac—Nausea—Prednisone—hematologic cancer	3.7e-06	2.86e-05	CcSEcCtD
Diclofenac—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.69e-06	2.85e-05	CcSEcCtD
Diclofenac—Pruritus—Methotrexate—hematologic cancer	3.69e-06	2.85e-05	CcSEcCtD
Diclofenac—Hypersensitivity—Epirubicin—hematologic cancer	3.59e-06	2.78e-05	CcSEcCtD
Diclofenac—Urticaria—Doxorubicin—hematologic cancer	3.58e-06	2.77e-05	CcSEcCtD
Diclofenac—Body temperature increased—Doxorubicin—hematologic cancer	3.57e-06	2.76e-05	CcSEcCtD
Diclofenac—Abdominal pain—Doxorubicin—hematologic cancer	3.57e-06	2.76e-05	CcSEcCtD
Diclofenac—Diarrhoea—Methotrexate—hematologic cancer	3.56e-06	2.75e-05	CcSEcCtD
Diclofenac—Asthenia—Epirubicin—hematologic cancer	3.5e-06	2.7e-05	CcSEcCtD
Diclofenac—Pruritus—Epirubicin—hematologic cancer	3.45e-06	2.67e-05	CcSEcCtD
Diclofenac—Dizziness—Methotrexate—hematologic cancer	3.45e-06	2.66e-05	CcSEcCtD
Diclofenac—Diarrhoea—Epirubicin—hematologic cancer	3.34e-06	2.58e-05	CcSEcCtD
Diclofenac—Hypersensitivity—Doxorubicin—hematologic cancer	3.32e-06	2.57e-05	CcSEcCtD
Diclofenac—Vomiting—Methotrexate—hematologic cancer	3.31e-06	2.56e-05	CcSEcCtD
Diclofenac—Rash—Methotrexate—hematologic cancer	3.28e-06	2.54e-05	CcSEcCtD
Diclofenac—Dermatitis—Methotrexate—hematologic cancer	3.28e-06	2.54e-05	CcSEcCtD
Diclofenac—Headache—Methotrexate—hematologic cancer	3.26e-06	2.52e-05	CcSEcCtD
Diclofenac—Asthenia—Doxorubicin—hematologic cancer	3.24e-06	2.5e-05	CcSEcCtD
Diclofenac—Dizziness—Epirubicin—hematologic cancer	3.22e-06	2.49e-05	CcSEcCtD
Diclofenac—Pruritus—Doxorubicin—hematologic cancer	3.19e-06	2.47e-05	CcSEcCtD
Diclofenac—Vomiting—Epirubicin—hematologic cancer	3.1e-06	2.4e-05	CcSEcCtD
Diclofenac—Nausea—Methotrexate—hematologic cancer	3.09e-06	2.39e-05	CcSEcCtD
Diclofenac—Diarrhoea—Doxorubicin—hematologic cancer	3.09e-06	2.38e-05	CcSEcCtD
Diclofenac—Rash—Epirubicin—hematologic cancer	3.07e-06	2.38e-05	CcSEcCtD
Diclofenac—Dermatitis—Epirubicin—hematologic cancer	3.07e-06	2.37e-05	CcSEcCtD
Diclofenac—Headache—Epirubicin—hematologic cancer	3.05e-06	2.36e-05	CcSEcCtD
Diclofenac—Dizziness—Doxorubicin—hematologic cancer	2.98e-06	2.3e-05	CcSEcCtD
Diclofenac—Nausea—Epirubicin—hematologic cancer	2.9e-06	2.24e-05	CcSEcCtD
Diclofenac—Vomiting—Doxorubicin—hematologic cancer	2.87e-06	2.22e-05	CcSEcCtD
Diclofenac—Rash—Doxorubicin—hematologic cancer	2.84e-06	2.2e-05	CcSEcCtD
Diclofenac—Dermatitis—Doxorubicin—hematologic cancer	2.84e-06	2.2e-05	CcSEcCtD
Diclofenac—Headache—Doxorubicin—hematologic cancer	2.83e-06	2.18e-05	CcSEcCtD
Diclofenac—Nausea—Doxorubicin—hematologic cancer	2.68e-06	2.07e-05	CcSEcCtD
Diclofenac—PTGS1—Metabolism—PIK3CD—hematologic cancer	8.31e-07	1.22e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CREBBP—hematologic cancer	8.31e-07	1.22e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	8.28e-07	1.21e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CYCS—hematologic cancer	8.26e-07	1.21e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—NCOR1—hematologic cancer	8.22e-07	1.2e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GSTM1—hematologic cancer	8.22e-07	1.2e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TGFB1—hematologic cancer	8.22e-07	1.2e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	8.21e-07	1.2e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—ALB—hematologic cancer	8.2e-07	1.2e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—SRC—hematologic cancer	8.2e-07	1.2e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GSTM1—hematologic cancer	8.18e-07	1.2e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—NCOR1—hematologic cancer	8.18e-07	1.2e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CRABP1—hematologic cancer	8.17e-07	1.2e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—SLC22A1—hematologic cancer	8.17e-07	1.2e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—AKT1—hematologic cancer	8.15e-07	1.19e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MAPK3—hematologic cancer	8.1e-07	1.19e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	8.1e-07	1.19e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GSTP1—hematologic cancer	7.99e-07	1.17e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ALOX5—hematologic cancer	7.97e-07	1.17e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MAP2K1—hematologic cancer	7.93e-07	1.16e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—MTHFR—hematologic cancer	7.93e-07	1.16e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.92e-07	1.16e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—STAT3—hematologic cancer	7.91e-07	1.16e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—NRAS—hematologic cancer	7.89e-07	1.16e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MYC—hematologic cancer	7.88e-07	1.15e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CD—hematologic cancer	7.88e-07	1.15e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	7.87e-07	1.15e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TGFB1—hematologic cancer	7.86e-07	1.15e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3R1—hematologic cancer	7.85e-07	1.15e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GSTP1—hematologic cancer	7.8e-07	1.14e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	7.73e-07	1.13e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NUP98—hematologic cancer	7.72e-07	1.13e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PTEN—hematologic cancer	7.68e-07	1.12e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—KRAS—hematologic cancer	7.61e-07	1.12e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ABCB1—hematologic cancer	7.56e-07	1.11e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MAPK3—hematologic cancer	7.55e-07	1.11e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—FGF2—hematologic cancer	7.54e-07	1.11e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CG—hematologic cancer	7.51e-07	1.1e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ADCY7—hematologic cancer	7.49e-07	1.1e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NCOA3—hematologic cancer	7.49e-07	1.1e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—NQO1—hematologic cancer	7.46e-07	1.09e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CD44—hematologic cancer	7.46e-07	1.09e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3R1—hematologic cancer	7.44e-07	1.09e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NUP214—hematologic cancer	7.44e-07	1.09e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PTEN—hematologic cancer	7.4e-07	1.08e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.39e-07	1.08e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MYC—hematologic cancer	7.35e-07	1.08e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GSTM1—hematologic cancer	7.34e-07	1.08e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—NCOR1—hematologic cancer	7.34e-07	1.08e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—TGFB1—hematologic cancer	7.33e-07	1.07e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—EP300—hematologic cancer	7.32e-07	1.07e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	7.31e-07	1.07e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—MTR—hematologic cancer	7.29e-07	1.07e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ABCG2—hematologic cancer	7.29e-07	1.07e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—KRAS—hematologic cancer	7.28e-07	1.07e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GSTP1—hematologic cancer	7.28e-07	1.07e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—MTHFR—hematologic cancer	7.27e-07	1.06e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CB—hematologic cancer	7.24e-07	1.06e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—JAK2—hematologic cancer	7.23e-07	1.06e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—MTHFR—hematologic cancer	7.23e-07	1.06e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CG—hematologic cancer	7.21e-07	1.06e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GSTM1—hematologic cancer	7.16e-07	1.05e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—NCOR1—hematologic cancer	7.16e-07	1.05e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ENO2—hematologic cancer	7.15e-07	1.05e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CG—hematologic cancer	7.06e-07	1.04e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—EP300—hematologic cancer	7.06e-07	1.03e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYCS—hematologic cancer	7.06e-07	1.03e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MDM2—hematologic cancer	7.06e-07	1.03e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	7.05e-07	1.03e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	7.02e-07	1.03e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—PIK3CA—hematologic cancer	7e-07	1.02e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.99e-07	1.02e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CREBBP—hematologic cancer	6.96e-07	1.02e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTT1—hematologic cancer	6.93e-07	1.02e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ABCB1—hematologic cancer	6.89e-07	1.01e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CB—hematologic cancer	6.87e-07	1.01e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MTOR—hematologic cancer	6.87e-07	1.01e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CD4—hematologic cancer	6.85e-07	1e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PIK3CA—hematologic cancer	6.85e-07	1e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—KRAS—hematologic cancer	6.79e-07	9.95e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—SDC1—hematologic cancer	6.77e-07	9.92e-06	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TP53—hematologic cancer	6.77e-07	9.91e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GSTM1—hematologic cancer	6.69e-07	9.81e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—NCOR1—hematologic cancer	6.69e-07	9.81e-06	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PIK3CA—hematologic cancer	6.69e-07	9.8e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CREBBP—hematologic cancer	6.69e-07	9.8e-06	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PIK3CA—hematologic cancer	6.67e-07	9.77e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CG—hematologic cancer	6.66e-07	9.76e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CD—hematologic cancer	6.6e-07	9.67e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CREBBP—hematologic cancer	6.55e-07	9.6e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—ALB—hematologic cancer	6.51e-07	9.54e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—MTHFR—hematologic cancer	6.49e-07	9.5e-06	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TP53—hematologic cancer	6.47e-07	9.48e-06	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—HRAS—hematologic cancer	6.47e-07	9.48e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CDKN1B—hematologic cancer	6.44e-07	9.44e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.41e-07	9.38e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.37e-07	9.33e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CD—hematologic cancer	6.34e-07	9.29e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—MTHFR—hematologic cancer	6.33e-07	9.28e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.31e-07	9.25e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—ALB—hematologic cancer	6.26e-07	9.17e-06	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PTEN—hematologic cancer	6.26e-07	9.17e-06	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PIK3CA—hematologic cancer	6.24e-07	9.14e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3R1—hematologic cancer	6.23e-07	9.13e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GSTP1—hematologic cancer	6.22e-07	9.12e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CD—hematologic cancer	6.21e-07	9.1e-06	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—HRAS—hematologic cancer	6.19e-07	9.07e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CREBBP—hematologic cancer	6.18e-07	9.05e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—ALB—hematologic cancer	6.13e-07	8.98e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CG—hematologic cancer	6.11e-07	8.95e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CG—hematologic cancer	6.07e-07	8.9e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.02e-07	8.82e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3R1—hematologic cancer	5.99e-07	8.77e-06	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—EP300—hematologic cancer	5.97e-07	8.75e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CDKN1A—hematologic cancer	5.95e-07	8.71e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PTEN—hematologic cancer	5.93e-07	8.69e-06	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—IL6—hematologic cancer	5.93e-07	8.68e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—MTHFR—hematologic cancer	5.92e-07	8.67e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ABCB1—hematologic cancer	5.89e-07	8.63e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3R1—hematologic cancer	5.86e-07	8.59e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CD—hematologic cancer	5.86e-07	8.58e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—ALB—hematologic cancer	5.78e-07	8.47e-06	CbGpPWpGaD
Diclofenac—ABCC1—Disease—HRAS—hematologic cancer	5.77e-07	8.45e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CD44—hematologic cancer	5.76e-07	8.44e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NQO1—hematologic cancer	5.76e-07	8.44e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CB—hematologic cancer	5.75e-07	8.42e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—NCOR1—hematologic cancer	5.72e-07	8.38e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GSTM1—hematologic cancer	5.72e-07	8.38e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.72e-07	8.38e-06	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—AKT1—hematologic cancer	5.71e-07	8.37e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CREBBP—hematologic cancer	5.66e-07	8.29e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—EP300—hematologic cancer	5.66e-07	8.29e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CREBBP—hematologic cancer	5.63e-07	8.25e-06	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—AKT1—hematologic cancer	5.6e-07	8.2e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3R1—hematologic cancer	5.53e-07	8.1e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CB—hematologic cancer	5.53e-07	8.1e-06	CbGpPWpGaD
Diclofenac—ABCC1—Disease—IL6—hematologic cancer	5.52e-07	8.09e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—SRC—hematologic cancer	5.5e-07	8.06e-06	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—AKT1—hematologic cancer	5.47e-07	8.01e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CG—hematologic cancer	5.45e-07	7.99e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYCS—hematologic cancer	5.45e-07	7.98e-06	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—AKT1—hematologic cancer	5.45e-07	7.98e-06	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PIK3CA—hematologic cancer	5.42e-07	7.94e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	5.42e-07	7.93e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CB—hematologic cancer	5.41e-07	7.93e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CD—hematologic cancer	5.37e-07	7.86e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CD—hematologic cancer	5.34e-07	7.82e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CG—hematologic cancer	5.32e-07	7.79e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—STAT3—hematologic cancer	5.31e-07	7.77e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—ALB—hematologic cancer	5.3e-07	7.76e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—NRAS—hematologic cancer	5.29e-07	7.76e-06	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PIK3CA—hematologic cancer	5.22e-07	7.65e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.21e-07	7.64e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CB—hematologic cancer	5.1e-07	7.48e-06	CbGpPWpGaD
Diclofenac—ABCC1—Disease—AKT1—hematologic cancer	5.1e-07	7.46e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MAPK3—hematologic cancer	5.07e-07	7.43e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3R1—hematologic cancer	5.07e-07	7.43e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—MTHFR—hematologic cancer	5.05e-07	7.41e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CREBBP—hematologic cancer	5.05e-07	7.4e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3R1—hematologic cancer	5.04e-07	7.38e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CG—hematologic cancer	4.97e-07	7.28e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PTEN—hematologic cancer	4.97e-07	7.28e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CREBBP—hematologic cancer	4.93e-07	7.23e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MYC—hematologic cancer	4.93e-07	7.22e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—TGFB1—hematologic cancer	4.92e-07	7.21e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTP1—hematologic cancer	4.8e-07	7.04e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CD—hematologic cancer	4.79e-07	7.02e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PTEN—hematologic cancer	4.78e-07	7e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—EP300—hematologic cancer	4.74e-07	6.94e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ALB—hematologic cancer	4.73e-07	6.93e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CB—hematologic cancer	4.68e-07	6.86e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PTEN—hematologic cancer	4.68e-07	6.85e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CD—hematologic cancer	4.68e-07	6.85e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CB—hematologic cancer	4.65e-07	6.82e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—ALB—hematologic cancer	4.62e-07	6.76e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CREBBP—hematologic cancer	4.61e-07	6.75e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—KRAS—hematologic cancer	4.56e-07	6.68e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—EP300—hematologic cancer	4.55e-07	6.67e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ABCB1—hematologic cancer	4.55e-07	6.66e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3R1—hematologic cancer	4.52e-07	6.63e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—EP300—hematologic cancer	4.46e-07	6.54e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.45e-07	6.53e-06	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—AKT1—hematologic cancer	4.43e-07	6.48e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3R1—hematologic cancer	4.42e-07	6.47e-06	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CA—hematologic cancer	4.42e-07	6.47e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NCOR1—hematologic cancer	4.41e-07	6.47e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTM1—hematologic cancer	4.41e-07	6.47e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PTEN—hematologic cancer	4.41e-07	6.46e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CD—hematologic cancer	4.37e-07	6.4e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ALB—hematologic cancer	4.31e-07	6.32e-06	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—AKT1—hematologic cancer	4.27e-07	6.25e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CG—hematologic cancer	4.25e-07	6.22e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—EP300—hematologic cancer	4.21e-07	6.16e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CA—hematologic cancer	4.19e-07	6.13e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CB—hematologic cancer	4.18e-07	6.12e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3R1—hematologic cancer	4.13e-07	6.04e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CB—hematologic cancer	4.08e-07	5.97e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PTEN—hematologic cancer	4.04e-07	5.92e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PTEN—hematologic cancer	4.02e-07	5.89e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CREBBP—hematologic cancer	3.94e-07	5.77e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.9e-07	5.72e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—HRAS—hematologic cancer	3.87e-07	5.67e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—EP300—hematologic cancer	3.86e-07	5.65e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—EP300—hematologic cancer	3.83e-07	5.62e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CB—hematologic cancer	3.81e-07	5.58e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CD—hematologic cancer	3.73e-07	5.47e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—IL6—hematologic cancer	3.71e-07	5.43e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ALB—hematologic cancer	3.69e-07	5.4e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PTEN—hematologic cancer	3.61e-07	5.29e-06	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—AKT1—hematologic cancer	3.61e-07	5.29e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3R1—hematologic cancer	3.53e-07	5.17e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PTEN—hematologic cancer	3.52e-07	5.16e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CA—hematologic cancer	3.51e-07	5.14e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—EP300—hematologic cancer	3.44e-07	5.04e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—AKT1—hematologic cancer	3.42e-07	5.01e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CA—hematologic cancer	3.37e-07	4.94e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—EP300—hematologic cancer	3.36e-07	4.92e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CA—hematologic cancer	3.3e-07	4.83e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTEN—hematologic cancer	3.29e-07	4.82e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CG—hematologic cancer	3.28e-07	4.8e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CB—hematologic cancer	3.25e-07	4.77e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—EP300—hematologic cancer	3.14e-07	4.6e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CA—hematologic cancer	3.11e-07	4.56e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CREBBP—hematologic cancer	3.04e-07	4.45e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.88e-07	4.22e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—AKT1—hematologic cancer	2.86e-07	4.2e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CA—hematologic cancer	2.85e-07	4.18e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ALB—hematologic cancer	2.84e-07	4.17e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CA—hematologic cancer	2.84e-07	4.16e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTEN—hematologic cancer	2.81e-07	4.12e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—AKT1—hematologic cancer	2.75e-07	4.03e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.72e-07	3.99e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—AKT1—hematologic cancer	2.7e-07	3.95e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—EP300—hematologic cancer	2.68e-07	3.93e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CA—hematologic cancer	2.55e-07	3.73e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—AKT1—hematologic cancer	2.54e-07	3.72e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.51e-07	3.68e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CA—hematologic cancer	2.49e-07	3.64e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—AKT1—hematologic cancer	2.33e-07	3.41e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CA—hematologic cancer	2.32e-07	3.4e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—AKT1—hematologic cancer	2.32e-07	3.39e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTEN—hematologic cancer	2.17e-07	3.18e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—AKT1—hematologic cancer	2.08e-07	3.05e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—EP300—hematologic cancer	2.07e-07	3.03e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—AKT1—hematologic cancer	2.03e-07	2.97e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.98e-07	2.91e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—AKT1—hematologic cancer	1.9e-07	2.78e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—AKT1—hematologic cancer	1.62e-07	2.37e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.53e-07	2.24e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—AKT1—hematologic cancer	1.25e-07	1.83e-06	CbGpPWpGaD
